The global AI-Enabled drug discovery and clinical trials market size was US$ 325 million in 2021. The global AI-Enabled Drug discovery and clinical trials market is forecast to grow to US$ 2440 ...

There are currently no available treatment options for any form of frontotemporal dementia that have been approved by the EMA ...

As the first cohort of patients are dosed as part of the first stage of the Phase II trial, the company has announced the ...

The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Investigators said patients experienced adverse effects in line with those expected for myeloablative conditioning with ...

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...

Algorae Pharmaceuticals says its new AI-168 drug candidate shows early potential to improve on treatments to protect the ...

Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into its ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themsel ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which ...

Benralizabam, a monoclonal antibody, did a better job than steroids at reducing respiratory symptoms like coughing, wheezing, ...